These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17227241)

  • 1. [Hypoadiponectinemia: a cardiovascular risk factor in uremia. A view from the evidence].
    Estrada PN; Bajo MA; del Peso G; Iglesias P; Díez JJ; Fernández-Reyes MJ; Grande C; Sánchez Hernández R; Selgas R
    Nefrologia; 2006; 26(6):653-7. PubMed ID: 17227241
    [No Abstract]   [Full Text] [Related]  

  • 2. [Risk factors and cardiovascular disease in uremic patients].
    Valdés F; Morales JM
    Nefrologia; 2002; 22 Suppl 4():1-6. PubMed ID: 12123136
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
    Helal I; Smaoui W; Hamida FB; Ouniss M; Aderrahim E; Hedri H; Elyounsi F; Maiz HB; Abdallah TB; Kheder A
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):59-62. PubMed ID: 20061694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of plasma adiponectin and cardiovascular risk profiles in nondiabetic uremic patients on peritoneal dialysis.
    Tsao YT; Hsu YJ; Chu NF; Lai CH; Chiu JS; Lin SH
    J Nephrol; 2008; 21(5):744-52. PubMed ID: 18949730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22).
    Wilson SR; Sabatine MS; Wiviott SD; Ray KK; De Lemos JA; Zhou S; Rifai N; Cannon CP; Morrow DA;
    Am Heart J; 2011 Jun; 161(6):1147-55.e1. PubMed ID: 21641362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of PPAR-gamma agonist on adiponectin levels in the metabolic syndrome: lessons from the high fructose fed rat model.
    Sharabi Y; Oron-Herman M; Kamari Y; Avni I; Peleg E; Shabtay Z; Grossman E; Shamiss A
    Am J Hypertens; 2007 Feb; 20(2):206-10. PubMed ID: 17261469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of PPAR gamma agonists on cardiovascular function in obese, non-diabetic patients.
    Panunti B; Fonseca V
    Vascul Pharmacol; 2006 Jul; 45(1):29-35. PubMed ID: 16777491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro peritoneal dialysis.
    Van Biesen W; Verbeke F; Vanholder R
    Nephrol Dial Transplant; 2007 Jan; 22(1):53-8. PubMed ID: 17050633
    [No Abstract]   [Full Text] [Related]  

  • 9. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.
    Noordzij M; Korevaar JC; Bos WJ; Boeschoten EW; Dekker FW; Bossuyt PM; Krediet RT
    Nephrol Dial Transplant; 2006 Sep; 21(9):2513-20. PubMed ID: 16799173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin plasma levels are increased by atorvastatin treatment in subjects at high cardiovascular risk.
    Blanco-Colio LM; Martín-Ventura JL; Gómez-Guerrero C; Masramon X; de Teresa E; Farsang C; Gaw A; Gensini G; Leiter LA; Langer A; Egido J
    Eur J Pharmacol; 2008 May; 586(1-3):259-65. PubMed ID: 18374327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study.
    Becker B; Kronenberg F; Kielstein JT; Haller H; Morath C; Ritz E; Fliser D;
    J Am Soc Nephrol; 2005 Apr; 16(4):1091-8. PubMed ID: 15743998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
    Heinz J; Kropf S; Luley C; Dierkes J
    Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro haemodialysis.
    Segall L; Covic A
    Nephrol Dial Transplant; 2007 Jan; 22(1):59-63. PubMed ID: 17099221
    [No Abstract]   [Full Text] [Related]  

  • 14. Does statin therapy improve cardiovascular outcomes in patients with type 2 diabetes receiving hemodialysis?
    Kwan BC; Beddhu S; Kronenberg F; Cheung AK
    Nat Clin Pract Nephrol; 2006 Feb; 2(2):76-7. PubMed ID: 16932397
    [No Abstract]   [Full Text] [Related]  

  • 15. [Peritoneal dialysis and insulin resistance in patients with chronic kidney disease due to nondiabetic nephropathy].
    Wesołowski P; Saracyn M; Nowak Z; Wańkowicz Z
    Pol Merkur Lekarski; 2008 Apr; 24(142):359-63. PubMed ID: 18634374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular outcomes and their relationships to lipoprotein components in patients with and without chronic kidney disease: results from the IDEAL trial.
    Holme I; Fayyad R; Faergeman O; Kastelein JJ; Olsson AG; Tikkanen MJ; Larsen ML; Lindahl C; Holdaas H; Pedersen TR;
    J Intern Med; 2010 Jun; 267(6):567-75. PubMed ID: 20141566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic kidney disease as a cardiovascular risk factor.
    Best PJ; Holmes DR
    Am Heart J; 2003 Mar; 145(3):383-6. PubMed ID: 12660658
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular problems in dialysis patients: impact on survival.
    Sidhu MS; Dellsperger KC
    Adv Perit Dial; 2010; 26():47-52. PubMed ID: 21348379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing a peritoneal dialysis patient with high risk for cardiovascular disease.
    Pecoits-Filho R
    Nephron Clin Pract; 2010; 116(4):c283-8. PubMed ID: 20639674
    [No Abstract]   [Full Text] [Related]  

  • 20. [Potential of plasma adiponectin concentrations as a predictive marker for in-stent restenosis after percutaneous coronary intervention in patients on hemodialysis].
    Nishimura M; Takahashi H
    Rinsho Byori; 2011 Aug; 59(8):795-800. PubMed ID: 21942090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.